FORTE BIOSCIENCES, INC. Cash and Restricted Cash
FORTE BIOSCIENCES, INC. (FBRX) had Cash and Restricted Cash of $49.63 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $49.63M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $58.22M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $76.96M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $93.41M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $49.63M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $58.22M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $76.96M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $93.41M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $106.14M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $45.86M 10-Q · filed 2026-05-11 |
| 2024-12-31 | $22.24M 10-Q · filed 2026-08-12 |
| 2024-09-30 | $16.36M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $24.50M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $30.44M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $37.13M 10-K · filed 2026-03-31 |
| 2023-09-30 | $46.19M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $20.44M 10-Q · filed 2024-08-14 |
| 2023-03-31 | $35.90M 10-Q · filed 2024-05-13 |
| 2022-12-31 | $41.10M 10-K · filed 2025-03-28 |
| 2022-09-30 | $44.05M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $38.55M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $40.03M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $42.04M 10-K · filed 2024-03-18 |
| 2021-09-30 | $45.66M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $50.80M 10-Q · filed 2022-08-15 |
| 2021-03-31 | $54.76M 10-Q · filed 2022-05-16 |
| 2020-12-31 | $58.77M 10-K · filed 2023-03-31 |
| 2020-09-30 | $20.18M 10-Q · filed 2021-11-08 |
| 2020-06-30 | $27.75M 10-Q · filed 2021-08-16 |
| 2020-03-31 | $4.12M 10-Q · filed 2021-05-10 |
| 2019-12-31 | $6.94M 10-K · filed 2022-03-31 |
| 2019-09-30 | $7.68M 10-Q · filed 2020-11-09 |
| 2019-06-30 | $8.31M 10-Q · filed 2020-08-10 |
| 2018-12-31 | $5.02M 10-K · filed 2021-03-16 |